A novel GLA mutation in a Korean boy with an early cardiac manifestation of Fabry disease.
- Author:
Soonhak KWON
1
;
Jin Sung PARK
;
Jae Hun JUNG
;
Su Kyeong HWANG
;
Yeo Hyang KIM
;
Yun Jeong LEE
Author Information
- Publication Type:Case Report
- Keywords: Fabry disease; Lysosomal storage diseases; α-Galactosidase
- MeSH: Angiokeratoma; Child; Cornea; Fabry Disease*; Humans; Hypertrophy, Left Ventricular; Hypohidrosis; Lysosomal Storage Diseases; Male*; Mothers; Neurologic Manifestations; Plasma; Siblings
- From:Journal of Genetic Medicine 2018;15(1):28-33
- CountryRepublic of Korea
- Language:English
- Abstract: Fabry disease (FD) is a rare X-linked lysosomal storage disorder caused by the deficiency of α-galactosidase A. Patients with classical FD present acroparesthesia, hypohidrosis, cornea verticillata, disseminated angiokeratoma, and microalbuminuria in childhood, and develop life-threatening renal, cardiac, and cerebrovascular complications typically after the fourth decade of life. To date, more than 700 mutations responsible for FD have been identified in the human GLA gene. Herein, we report a novel GLA mutation, c.1117_1141del25 (p.Gly373Profs*10), identified in an 11-year-old Korean boy with FD presenting early cardiac and neurologic manifestation and in other affected family members. The boy had acroparesthesia, hypohidrosis, cornea verticillata, and left ventricular hypertrophy. His mother and sister also had acroparesthesia. Two males on the mother's side had similar pain and died of unknown causes. The plasma α-galactosidase A activity (4.1 nmol/hr/mg protein) of the patient was markedly lower than the mean value of the controls. The plasma level of globotriaosylsphingosine was elevated in the patient and all the carriers. We concluded the novel GLA mutation c.1117_1141del25 is a pathogenic mutation for FD, probably related to the early cardiac manifestation of FD.
